NIAGEN BIOSCIENCE, INC. Selling Expense
NIAGEN BIOSCIENCE, INC. (NAGE) reported Selling Expense of $3.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2026-08-04
- NIAGEN BIOSCIENCE, INC. selling expense for the quarter ending 2026-06-30 was $3.07M, a 11.06% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. selling expense for the quarter ending 2026-03-31 was $2.87M, a 7.59% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. selling expense for the quarter ending 2025-12-31 was $2.92M, a 4.17% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. selling expense for the quarter ending 2025-09-30 was $2.90M, a 22.32% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. selling expense for fiscal 2025 was $11.26M, a 14.61% increase from fiscal 2024.
- NIAGEN BIOSCIENCE, INC. selling expense for fiscal 2024 was $9.82M, a 11.42% increase from fiscal 2023.
- NIAGEN BIOSCIENCE, INC. selling expense for fiscal 2023 was $8.81M.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.07M 10-Q · filed 2026-08-04 | $5.94M 10-Q · filed 2026-08-04 | $8.86M derived: sum of 3 quarters · filed 2026-08-04 | $11.77M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $2.87M 10-Q · filed 2026-05-06 | $5.79M derived: sum of 2 quarters · filed 2026-05-06 | $8.69M derived: sum of 3 quarters · filed 2026-05-06 | $11.46M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $5.83M derived: sum of 2 quarters · filed 2026-03-04 | $8.59M derived: sum of 3 quarters · filed 2026-08-04 | $11.26M 10-K · filed 2026-03-04 |
| 2025-09-30 | $2.90M 10-Q · filed 2025-11-04 | $5.67M derived: sum of 2 quarters · filed 2026-08-04 | $8.33M 10-Q · filed 2025-11-04 | $11.14M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.77M 10-Q · filed 2026-08-04 | $5.43M 10-Q · filed 2026-08-04 | $8.23M derived: sum of 3 quarters · filed 2026-08-04 | $10.61M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.66M 10-Q · filed 2026-05-06 | $5.47M derived: sum of 2 quarters · filed 2026-05-06 | $7.84M derived: sum of 3 quarters · filed 2026-05-06 | $10.14M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $5.18M derived: sum of 2 quarters · filed 2026-03-04 | $7.48M derived: sum of 3 quarters · filed 2026-03-04 | $9.82M 10-K · filed 2026-03-04 |
| 2024-09-30 | $2.38M 10-Q · filed 2025-11-04 | $4.67M derived: sum of 2 quarters · filed 2025-11-04 | $7.02M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $2.30M 10-Q · filed 2025-08-06 | $4.64M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $2.34M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $8.81M 10-K · filed 2025-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |